兩連板的亞寶藥業(600351.SH):公司市盈率指標已顯著高於行業平均水平
格隆匯 8 月 4日丨連續2個漲停的亞寶藥業(600351.SH)發佈股票交易異常波動公告,經公司自查並書面徵詢控股股東及實際控制人,截至公告披露日,確認不存在應披露而未披露的重大信息。
公司2020年第一季度業績同比下滑明顯,公司2020年第一季度實現營業收入6.24億元,同比減少24.09%;歸屬於上市公司股東的淨利潤3998.58萬元,同比減少46.83%;歸屬於上市公司股東的扣除非經常性損益的淨利潤3454.31萬元,同比減少52.35%(上述財務數據未經審計),敬請廣大投資者注意業績風險。
公司市盈率指標已顯著高於行業平均水平,根據中證指數有限公司提供的證監會行業市盈率數據,截止2020年8月4日,公司所在醫藥製造業最新行業平均靜態市盈率為61.83,滾動市盈率為62.96,公司靜態市盈率為383.70,滾動市盈率為-250.47。
2020年7月14日,公司發佈《亞寶藥業集團股份有限公司股東集中競價減持股份計劃公告》,控股股東山西亞寶投資集團有限公司計劃通過集中競價方式在2020年8月5日至2021年2月1日期間減持公司股份不超過1540萬股,敬請廣大投資者注意相關風險。
敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.